Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110927200 on December 18, 2001

J. Biol. Chem., Vol. 277, Issue 13, 11392-11400, March 29, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/13/11392    most recent
M110927200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryson, J. M.
Right arrow Articles by Robey, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryson, J. M.
Right arrow Articles by Robey, R. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Increased Hexokinase Activity, of Either Ectopic or Endogenous Origin, Protects Renal Epithelial Cells against Acute Oxidant-induced Cell Death*

Jane M. BrysonDagger §, Platina E. CoyDagger §, Kathrin Gottlob, Nissim Hay, and R. Brooks RobeyDagger §||**

From the Dagger  Department of Medicine, Section of Nephrology, || Department of Physiology & Biophysics, and  Department of Molecular Genetics, College of Medicine, University of Illinois, Chicago and § Veterans Affairs Chicago Health Care System, West Side Division, Chicago, Illinois 60612

Received for publication, November 14, 2001, and in revised form, December 14, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Glucose (Glc) metabolism protects cells against oxidant injury. By virtue of their central position in both Glc uptake and utilization, hexokinases (HKs) are ideally suited to contribute to these effects. Compatible with this hypothesis, endogenous HK activity correlates inversely with injury susceptibility in individual renal cell types. We recently reported that ectopic HK expression mimics the anti-apoptotic effects of growth factors in cultured fibroblasts, but anti-apoptotic roles for HKs have not been examined in other cell types or in a cellular injury model. We therefore evaluated HK overexpression for the ability to mitigate acute oxidant-induced cell death in an established epithelial cell culture injury model. In parallel, we examined salutary heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) treatment for the ability to 1) increase endogenous HK activity and 2) mimic the protective effects of ectopic HK expression. Both HK overexpression and HB-EGF increased Glc-phosphorylating capacity and metabolism, and these changes were associated with markedly reduced susceptibility to acute oxidant-induced apoptosis. The uniform Glc dependence of these effects suggests an important adaptive role for Glc metabolism, and for HK activity in particular, in the promotion of epithelial cell survival. These findings also support the contention that HKs contribute to the protective effects of growth factors.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Glucose (Glc)1 metabolism plays a critical role in the protection of a variety of cell types against oxidant-induced cell death (1-9). The mechanisms underlying these cytoprotective effects are poorly understood, but contributions by both altered energy metabolism and cellular redox status have been suggested. Hexokinases (HKs) play a central role in both the uptake and utilization of Glc by catalyzing the first committed step of its metabolism, the phosphorylation of Glc to yield Glc 6-phosphate. By this mechanism, HKs maintain the downhill concentration gradient that permits facilitated Glc entry into cells. They also initiate all major pathways of Glc utilization and are ideally positioned to influence metabolic flux through both the glycolytic and the pentose phosphate pathways. Glycolytic flux is intimately linked to cellular energy metabolism, whereas pentose phosphate pathway flux plays a pivotal role in maintaining the cellular redox state. In principle, therefore, HK activity may directly contribute to the salutary effects associated with Glc metabolism in the setting of oxidative stress.

Three high affinity HK isoforms, HKI, HKII, and HKIII, are expressed in the mammalian kidney (10). Of these, HKI constitutes the principal renal isoform and accounts for roughly two-thirds of the total Glc-phosphorylating capacity of the normal kidney. The remaining HK activity is equally attributable to the two lower abundance renal isoforms, HKII and HKIII. Very little is known, however, about the normal expression, regulation, or function of individual HK isoforms in specific renal cell types. Cortical HK activity is increased in a variety of conditions associated with structural or functional alterations in the kidney (11-14), but the specific cell types and HK isoforms associated with these changes have not been defined. Given the substantial proximal tubular composition of the renal cortex, it is reasonable to assume that this nephron segment contributes significantly to these changes.

The proximal tubule plays a number of centrally important roles in normal renal physiology. This nephron segment also exhibits marked susceptibility to both oxidative and toxic injury in vivo and represents the principal renal cell type affected by a wide variety of pathophysiologic conditions. Because a general inverse correlation exists between endogenous HK activity and injury susceptibility in individual renal cell types (15-18), we hypothesized that HK activity may constitute an intrinsic cellular protective mechanism and play important adaptive roles in cellular responses to oxidative stress. To directly test this hypothesis and to better understand this important family of enzymes in the kidney, we first examined the functional consequences of ectopic HK expression in an established cell culture model of acute oxidant-induced proximal tubule cell injury (19-21). We then investigated whether changes in endogenous HK activity could contribute to the well-described salutary effects of growth factors on this cell type (22). Heparin-binding EGF-like growth factor (HB-EGF) was specifically selected for study on the basis of its increased renal expression during recovery from acute ischemic injury (23), as well as the demonstrated ability of the closely related family member EGF to ameliorate toxic and ischemic renal injury in vivo (22, 24-26). These findings have led some investigators to propose protective and/or reparative roles for HB-EGF in the oxidant injury associated with renal ischemia-reperfusion (22, 23), so we directly tested this growth factor for the ability to both increase endogenous proximal tubule cell HK activity and mimic the protective effects of HK overexpression. In parallel, individual protective effects associated with either ectopic or endogenous HK activity were specifically examined for dependence upon the availability of Glc.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents-- All cell culture reagents, including serum and media additives, were supplied by Invitrogen (Grand Island, NY). Grade I yeast Glc 6-phosphate dehydrogenase and a lactate dehydrogenase (LDH) activity detection kit were purchased from Roche Molecular Biochemicals (Indianapolis, IN). The chemical fluorophores 4',6'-diamidino-2-phenylindole (DAPI), propidium iodide (PI), and YO-PRO-1 were obtained from Molecular Probes (Eugene, OR). All other reagents, including beta -NADP, ATP, and recombinant human HB-EGF, were from Sigma Chemical Co. (St. Louis, MO) unless otherwise specified.

Cell Culture-- Mycoplasma-free HsPTC2 (Homo sapiens Proximal Tubule Cells) were obtained from the American Type Culture Collection (Rockville, MD) at passage 15. These cells are clonally derived from normal adult human proximal tubule cells that have been immortalized by transduction with human papillomavirus (HPV 16) E6 and E7 genes (19). They exhibit both biochemical and morphological features of normal proximal tubule cells in culture (19, 27) and represent an established cell culture model of oxidant-induced proximal tubule injury (19-21). Cells were routinely grown in monolayer culture on polystyrene dishes (Falcon, Becton Dickinson, Franklin Lakes, NJ) or uncoated glass chamber slides (LabTek II, Nalge Nunc, Naperville, IL). Normal growth medium consisted of standard Dulbecco's modified Eagle:Ham's F-12 (1:1) medium supplemented with 5% fetal bovine serum as described previously (27) but with the following modifications: The medium was buffered with 20 mM HEPES, and the Glc content was reduced to 7.5 mM. Cells were maintained at 37 °C in a humidified 5% CO2 incubator, and all experiments were performed between passages 15 and 30 to minimize the effects of phenotypic variation in continuous culture. Cells were also routinely serum-deprived for 16-24 h to induce quiescence prior to testing.

Adenoviral Transgene Delivery and Expression-- Recombinant replication-deficient adenoviruses expressing HKI (rAd-HKI), the GLUT1 facilitative Glc transporter (rAd-GLUT1), and a beta -galactosidase reporter gene (rAd-LacZ) (28) were obtained from Dr. Christopher B. Newgard (University of Texas Southwestern Medical Center, Dallas, TX) and were used to transfect quiescent HsPTC monolayers as described previously (29). Ectopic HKI expression was monitored by coupled enzymatic HK assays (see below), and beta -galactosidase expression in paired LacZ-transfected control cells was monitored by a standard cytochemical method as detailed previously (30). Susceptibility to oxidant-induced cell death was routinely examined 24 h following transfection, when transgene expression was maximal.

Hexokinase Assays-- Whole cell lysates were prepared by brief sonication (30-60 J) in ice-cold homogenization buffer (45 mM Tris-HCl, 50 mM KH2PO4, 10 mM Glc, 11.1 mM monothioglycerol, 0.5 mM EDTA, 0.2% (v/v) Triton X-100, pH 8.2), and HK activity was measured as the total Glc-phosphorylating capacity of fresh lysates using a standard Glc 6-phosphate dehydrogenase-coupled assay as described previously (31, 32) with minor modifications. The final assay mixture consisted of 1 unit/ml Glc 6-phosphate dehydrogenase, 0.5 mg/ml beta -NADP, 6.7 mM ATP, 7 mM MgCl2, 4 mM Glc, 2.5 mM KH2PO4, 1 mM NaH2PO4, 11.1 mM monothioglycerol, 0.01% (v/v) Triton X-100, 25 µM EDTA, and 45 mM Tris-HCl, pH 8.5. Total cellular protein content was assessed by the method of Bradford (33) using bovine gamma -globulin (Bio-Rad) as a reference standard, and all data were expressed as specific HK activity in units per g of total protein, where 1 unit is defined as that amount of enzyme activity resulting in the coupled formation of 1 µmol of NADPH per min at 25 °C.

Metabolic Assays-- Glc utilization and lactate production were evaluated as described previously (31, 32) and were assayed as the net rates of Glc disappearance and lactate accumulation in the culture medium, respectively. For these experiments, cells were tested in normal growth medium containing 7.5 mM Glc and lacking both serum and phenol red. Where appropriate, medium aliquots were assayed colorimetrically for both Glc and lactate content. Net cellular reductive capacity was also monitored using a commercially available tetrazolium reduction assay (CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay, Promega; Madison, WI). This in situ assay, which relies on the ability of viable cells to reduce MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (34)) in the presence of the electron acceptor phenazine ethosulfate, is widely employed to monitor net cellular reductive capacity as an indicator of both proliferation and viability. Originally attributed to mitochondrial metabolism (35), it has subsequently been demonstrated that tetrazolium bioreduction to yield formazan chromophores is primarily extramitochondrial and largely involves the pyridine dinucleotides NADH and NADPH (36). It has also been shown that formazan generation is critically dependent upon both the uptake and continued metabolism of Glc (37, 38), presumably via the coupled reduction of pyridine dinucleotides. Thus, chromophore formation will necessarily reflect both ongoing metabolic activity and oxidative consumption of reduced nicotinamide cofactor pools. MTS reduction assays were performed according to the manufacturer's recommendations and were exploited to monitor net cellular reductive capacity in real-time as described previously (38).

Acute Oxidative Stress Model-- The oxidative stress model used for these studies was essentially as described by Zager and colleagues (19-21) with minor modifications. HsPTC cells were routinely grown to ~90% confluence in normal growth medium before serum deprivation overnight to induce quiescence. In preliminary testing, serum deprivation alone, for periods up to 24 h, was not sufficient to induce apoptosis in these cells.3 Quiescent cell monolayers were then exposed to H2O2 at concentrations up to 10 mM for as long as 3 h at 37 °C in Hanks' balanced salt solution (HBSS) containing physiologic levels of Glc (5.6 mM).

Cell Viability/Death Assays-- In initial experiments, cell death was monitored microscopically by the uptake of both YO-PRO-1 (39) and PI, fluorescent markers of apoptosis and necrosis, respectively. Quiescent HsPTC monolayers were exposed to H2O2 (0-10 mM) for up to 3 h at 37 °C in HBSS containing 1 µM YO-PRO-1 and/or 1.5 µM PI. The cellular uptake of both fluorophores was monitored, alone and in combination, using a Carl Zeiss LSM 410 laser scanning confocal microscope system equipped with an argon/krypton laser as previously described (40), and unstressed control cells were routinely analyzed in parallel to exclude direct toxic effects of the fluorophores. The exclusion of both YO-PRO-1 and PI from viable, non-apoptotic cells makes them useful to screen for cell death in real-time, but because not all cells are visualized by this method, additional measures are required for quantitative estimates of cell death. For this reason, quantitative assessment of apoptosis was performed under selected conditions by conventional DAPI staining and cell counting (29, 41). In these experiments, cells were fixed, where appropriate, by the direct addition of formaldehyde to the medium to a final concentration of 10% (v/v). Detached cells were allowed to settle and adhere to the slide before DAPI staining and analysis using a Zeiss Axioplan 2 fluorescence microscopy system equipped with a matched ultraviolet light source. Apoptotic cells were manually counted and expressed as a percentage of the total cell number. At least four independent fields of ~100 cells were scored for each experimental condition.

Cytolysis Assays-- Plasma membrane integrity was serially assessed by monitoring cytosolic lactate dehydrogenase (LDH) release into the culture medium using a commercially available assay kit (Roche Molecular Biochemicals) per the manufacturer's recommendations. In brief, LDH activity was colorimetrically assayed in cell-free aliquots of culture supernatants via the coupled enzymatic reduction of a tetrazolium salt to generate a formazan chromophore. The total releasable pool of cellular LDH activity was always assayed in identical paired cell monolayers following lysis with 1% (v/v) Triton X-100, and the proportion of the total activity in the supernatant was taken as an index of the degree of cell lysis.

Statistical Analysis-- All data are presented as the means ± S.E. for at least three independent experiments. Statistical comparisons were performed by two-tailed paired t-testing using a significance level of 95% and StatView 5.0.1 software for Macintosh computers (SAS Institute, Cary, NC).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

H2O2 Decreases Both HsPTC Viability and Net Cellular Reductive Capacity in a Time- and Concentration-dependent Manner-- To characterize the general response of HsPTC to acute oxidative stress, quiescent cell monolayers were exposed to varying concentrations of H2O2 (0-10 mM) in the presence of fluorescent indicators of apoptosis (1 µM YO-PRO-1) and/or necrosis (1.5 µM PI). H2O2 increased the cellular uptake of both fluorophores in a concentration- and time-dependent manner, with virtually all cells exhibiting YO-PRO-1 uptake and nuclear condensation characteristic of apoptosis within 2 h of exposure to 10 mM H2O2 (Fig. 1A). PI uptake exhibited similar H2O2 concentration dependence but typically lagged behind YO-PRO-1 uptake by 0.5-1.0 h.3 In addition to this temporal delay, PI uptake by cells incubated with both fluorophores was observed only in YO-PRO-1-staining apoptotic cells, suggesting the development of secondary necrotic changes in these cells. Acute oxidative stress was also associated with marked depression of in situ tetrazolium bioreduction (Fig. 1B). This effect was similarly concentration-dependent and was most marked at H2O2 concentrations associated with increased early apoptosis (Fig. 1A). Changes in net cellular reductive capacity, however, uniformly preceded the uptake of both YO-PRO-1 and PI, which is temporally compatible with roles for both metabolism and cellular redox status in this model of acute oxidant-induced cell death.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   H2O2 increases apoptosis and decreases cellular reductive capacity in a time- and concentration-dependent manner. A, confluent HsPTC monolayers were exposed to H2O2 at the indicated concentrations for up to 2.5 h at 37 °C in HBSS supplemented with 1 µM YO-PRO-1. Apoptotic cells rendered permeable to YO-PRO-1 are recognizable by characteristic green fluorescence and nuclear condensation when excited with the 488-nm line of an argon-krypton laser. Cells exposed to H2O2 increased YO-PRO-1 in both a time- and concentration-dependent manner. Propidium iodide (PI) uptake, visualized as red fluorescence when excited with the 567-nm line of an argon-krypton laser, was similarly increased, but the cellular uptake of PI was uniformly delayed relative to that of YO-PRO-1. In fact, PI uptake consistently lagged behind YO-PRO-1 uptake by as much as 0.5-1.0 h (data not shown). Light microscopic examination revealed equivalent numbers of attached cells for all conditions at the completion of the 2.5-h treatment period above. Treatment times >2.5 h, however, were associated with progressive cell detachment and morphologic changes associated with cell death (see below). The representative experiment depicted was repeated three times with similar results. B, H2O2 also decreased net cellular reductive capacity in a concentration-dependent manner, as assessed by the in situ reduction of the tetrazolium salt MTS to yield a formazan chromophore. These changes, which were most marked at concentrations associated with increased YO-PRO-1 uptake, temporally preceded the apoptosis-associated uptake of this fluorophore. A representative experiment, performed in triplicate and repeated twice with identical results, is depicted.

Adenoviral HKI Transgene Delivery Increases Total HK Activity in a Titer-dependent Manner-- To directly assess the functional consequences of primary increases in cellular Glc phosphorylating capacity, HsPTC were transfected with recombinant adenoviruses expressing either a beta -galactosidase reporter gene (rAd-LacZ) or an HKI transgene. As depicted in Fig. 2A, control adenoviral transfections using the beta -galactosidase-expressing vector (rAd-LacZ) resulted in uniform, titer-dependent reporter gene expression. HKI overexpression using a matched vector (rAd-HKI; Fig. 2B) similarly increased total HK activity in a titer-dependent manner. Basal HK activity (17 ± 1 units/g of protein) in untransfected HsPTC was comparable in magnitude to that reported previously for both this cell line (27) and for primary cultures of human proximal tubule cells (42). In paired cell monolayers, infection with rAd-HKI at a relative multiplicity of infection (m.o.i.) of ~1 increased total HK activity at 24 h by over 40% (25 ± 2 units/g of protein, p < 0.001), whereas a 10-fold higher viral titer increased total HK activity nearly 4-fold (64 ± 7 units/g of protein, p < 0.001).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 2.   Adenoviral HKI transgene delivery increases total HK activity in a concentration-dependent manner. Confluent cell monolayers were routinely transfected with matched recombinant pJM17-based adenoviruses (28) expressing a beta -galactosidase reporter gene (rAd-LacZ) or a rat HKI transgene (rAd-HKI). As shown in A, transfections with rAd-LacZ resulted in uniform, titer-dependent reporter gene expression, with virtually all cells expressing cytochemically detectable beta -galactosidase at viral multiplicities-of-infection (m.o.i.) >=  1. A representative set of control transfections is shown. As depicted in B, transfection with rAd-HKI resulted in similar titer-dependent HKI transgene expression. At an m.o.i. ~ 1, rAd-HKI increased total HK activity by over 40% at 24 h (*, p < 0.001). Exposure to a 10-fold greater titer of rAd-HKI (m.o.i. ~ 10) resulted in a corresponding 4-fold increase in total HK activity (*, p < 0.001). Higher viral titers were associated with much smaller increments in HK activity and were variably accompanied by evidence of cellular toxicity, ostensibly due to higher levels of native adenoviral gene product expression (29).

Cells Expressing Ectopic HKI Exhibit Decreased Susceptibility to Acute Oxidant-induced Cell Death-- beta -Galactosidase-expressing (+rAd-LacZ), recombinant HKI-expressing (+rAdHKI), and paired untransfected HsPTC cell monolayers were acutely exposed to H2O2 over a concentration range (1-10 mM) previously required to induce rapid oxidant-induced death in both these cells (19-21) and isolated proximal tubule segments (21, 43). As shown in Fig. 3, cells overexpressing HKI (+rAd-HKI, m.o.i. ~1; lower panels) exhibited improved cell morphology and attachment, as well as decreased uptake of both YO-PRO-1 and PI, relative to paired untransfected controls (wt; upper panels) or cells expressing a beta -galactosidase reporter gene (+rAd-LacZ, m.o.i. ~1; middle panels) when exposed to 10 mM H2O2 for 3 h. Qualitatively similar effects were observed at lower H2O2 concentrations, but they were temporally delayed and markedly extended the time frame required for analysis.3 The salutary benefits of ectopic HK expression were associated with modest increases in total HK activity (>40%) that were comparable in magnitude to those previously associated with reduced apoptosis in cultured fibroblasts following prolonged growth factor withdrawal (29). Additional protective benefits were not observed at the higher levels of HK activity associated with higher rAd-HKI titers, so all subsequent experiments were conducted at comparable functional titers (i.e. m.o.i. ~1), except where noted. The representative experiment depicted in Fig. 3 was repeated three times with identical results.


View larger version (94K):
[in this window]
[in a new window]
 
Fig. 3.   HsPTC expressing ectopic HKI exhibit decreased susceptibility to acute oxidant-induced cell death. Confluent HsPTC monolayers were exposed to 10 mM H2O2 for 3 h in the presence of both 1 µM YO-PRO-1 and 1 µg/ml PI. Ectopic HKI expression sufficient to increase total HK activity by >40% (see Fig. 2B; m.o.i. ~ 1) was associated with marked cytoprotective benefits. Cells overexpressing HKI (+rAd-HKI) exhibited improved cell morphology and attachment (left panels), increased plasma membrane integrity (center and right panels), and decreased apoptosis (right panels) when compared with beta -galactosidase-expressing (+rAd-LacZ) or untransfected (wt) control cells. A representative experiment, repeated twice with identical results, is depicted. The cellular uptake of PI temporally lagged behind that of YO-PRO-1 and was uniformly observed in YO-PRO-1-containing cells, consistent with the development of secondary necrotic changes. The longer incubation times required to observe PI uptake (typically >= 2.5 h) were frequently associated with increased cell detachment as shown.

HK Overexpression Decreases Cytolysis in Both Stressed and Unstressed HsPTC-- We also monitored the extracellular release of cytosolic LDH as a marker of plasma membrane integrity. Total cellular LDH content in these experiments remained stable and was not different in paired stressed and unstressed cells. Basal LDH release by unstressed cells averaged 10 ± 1% of the total cellular LDH content over 3 h. As depicted in Fig. 4, exposure to 1 mM H2O2 nearly doubled the rate of LDH release during this time period, whereas exposure to 10 mM H2O2 more than trebled this response (*, p < 0.05). These findings were both temporally and quantitatively compatible with the observed changes in cellular PI uptake by oxidant-stressed HsPTC. Ectopic HK expression by rAd-HKI prevented the increase in LDH release by cells exposed to 1 mM H2O2 in a titer-dependent manner (Fig. 5). Interestingly, HKI overexpression also decreased LDH release by unstressed cells, suggesting small, albeit significant (*, p < 0.05), salutary effects on basal apoptosis as well.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   H2O2 increases HsPTC lysis in a concentration-dependent manner. Acute oxidant-induced cell lysis was monitored as the release of cytosolic LDH into the culture medium. Basal LDH release by unstressed cells was consistently ~10% of the total cellular LDH content over this period and was comparable in magnitude to basal levels of cell lysis reported for isolated rat proximal tubules (43). An increase of ~3-fold in LDH release was observed within 3 h in the presence of 10 mM H2O2, and intermediate responses were observed in the presence of 1 or 5 mM H2O2 (*, p < 0.02 versus basal).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Ectopic HK expression increases cell viability in both stressed and unstressed HsPTC. As demonstrated in Fig. 4, total LDH release by cells exposed to 1 mM H2O2 for 3 h () was nearly 2-fold higher than that associated with paired, unstressed control cells (open circle , p < 0.02). However, prior transfection with rAd-HKI prevented oxidant-induced cytolysis in a titer-dependent manner and increased cell viability in unstressed control cells as well (*, p < 0.05 versus paired unstressed controls; dagger , p < 0.05 versus paired oxidant-stressed controls). All data represent the means ± S.E. for at least three independent measures, and error bars are depicted were they are larger than the symbols used to depict the means.

Ectopic HKI Expression Exerts Anti-apoptotic Effects That Correlate with Increased Cellular Glc Phosphorylating Capacity-- Apoptotic cell death was quantitatively assessed in DAPI-stained HsPTC by microscopic examination and manual counting of condensed and fragmented nuclei (29, 41). Both stressed (10 mM H2O2) and unstressed control cell monolayers were routinely scored for apoptosis in parallel with beta -galactosidase-, HKI-, or GLUT1-overexpressing cells. As shown in Fig. 6A, exposure of untransfected HsPTC to 10 mM H2O2 in the presence of 7.5 mM Glc more than doubled the number of apoptotic cells at 1 h. Ectopic HK expression (+rAd-HKI) largely prevented this increase (*, p < 0.05), in agreement with the corresponding decrease in YO-PRO-1 uptake described above. In contrast, both beta -galactosidase reporter gene expression (+rAd-LacZ) and facilitative Glc transporter overexpression (+rAd-GLUT1) failed to mimic the effects of ectopic HK expression on the fractional rate of oxidant-induced HsPTC apoptosis. It is pertinent to note, however, that, in individual experiments, GLUT1-overexpressing cells consistently exhibited oxidant-induced apoptotic rates that were intermediate between those observed for HKI-overexpressing cells and beta -galactosidase-expressing control cells. Pairwise analysis of the data at 1 h confirmed that apoptosis increased by 209 ± 50% (p < 0.02 versus unstressed controls) and 206 ± 49% (p < 0.02 versus unstressed controls) in beta -galactosidase-expressing and untransfected control cells, respectively. These responses were indistinguishable from one another (p = 0.93), whereas apoptosis in oxidant-stressed HKI-overexpressing cells increased by only 53 ± 12% (p < 0.05 versus oxidant-stressed beta -galactosidase-expressing and untransfected controls). The corresponding response in GLUT1-overexpressing cells (125 ± 30%) was intermediate between these extremes but never achieved statistical significance in these studies (p = 0.17 and p = 0.10 versus beta -galactosidase-expressing and untransfected control cells, respectively). As shown in Fig. 6B, total HK activity (17 ± 2 units/g of protein in untransfected HsPTC) was increased by HKI overexpression in these studies (24 ± 2 units/g of protein, p = 0.0003) but was not affected by either beta -galactosidase reporter gene expression (17 ± 1 units/g of protein, p = 0.72) or ectopic GLUT1 expression (18 ± 2 units/g of protein, p = 0.26).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Ectopic HKI expression prevents acute oxidant-induced apoptosis and increases cellular Glc phosphorylating capacity. A, exposure of untransfected HsPTC to 10 mM H2O2 () in the presence of 7.5 mM Glc rapidly and markedly increased the number of apoptotic cells. Neither beta -galactosidase reporter gene expression (+rAd-LacZ, open circle ) nor facilitative Glc transporter overexpression (+rAd-GLUT1, ) at comparable m.o.i. had a significant effect on the fractional rate of apoptosis in H2O2-stressed cells. In contrast, HKI overexpression (+rAd-HKI, black-diamond ) largely prevented this increase in oxidant-induced apoptosis (*, p < 0.05). These findings were consistent with the YO-PRO-1 uptake results shown in Figs. 1A and 3. All data depicted at 0, 0.5, and 1 h represent the means ± S.E. for at least three independent experiments. The data at 1.5 h (dagger ) represent results from a pair of independent experiments used to define the curves beyond 1 h, but excluded from statistical analysis because of sample size limitations. Error bars for all data are shown where they are larger than the symbols used to depict the means. As shown in B, the salutary effects of HKI overexpression (+rAd-HKI) were associated with an increase in total HK activity (*, p = 0.0003). In contrast, both beta -galactosidase reporter gene expression (+rAd-LacZ) and facilitative Glc transporter overexpression (+rAd-GLUT1), which failed to mimic the protective effects associated with rAd-HKI (A), did not increase HsPTC Glc-phosphorylating capacity (B).

The Salutary Effects of Ectopic HK Expression Require the Availability of Glc-- To examine whether the protective effects associated with increased HK activity depend upon substrate availability, we specifically examined the ability of rAd-HKI to mitigate acute oxidant-induced HsPTC apoptosis in both the presence and absence of Glc. As shown in Fig. 7, Glc removal from the medium during exposure to 10 mM H2O2 abrogated the cytoprotective effect of ectopic HKI expression. In addition, the rate of oxidant-induced apoptosis was actually enhanced in both untransfected and HKI-overexpressing HsPTC in the absence of Glc, suggesting intrinsic Glc-dependent protective mechanisms that presumably include endogenous HK activity.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 7.   The salutary effects of ectopic HK expression require substrate availability. As demonstrated in Fig. 6A, HKI overexpression (+rAd-HKI) prevented oxidant-induced apoptosis in the presence of 5.6 mM Glc (black-square; *, p < 0.03 versus paired untransfected control cells, ). Glc removal from the medium not only abrogated the protective effect of HKI overexpression, it enhanced the rate of oxidant-induced apoptosis in both HKI-overexpressing cells (; §, p < 0.04 and **, p = 0.007 versus HKI-overexpressing cells in the presence of Glc, black-square) and untransfected control cells (open circle ; dagger , p < 0.03 versus corresponding cells in the presence of Glc, ). In the absence of Glc, oxidant-induced apoptosis was indistinguishable between HKI-overexpressing cells () and untransfected cells (open circle ; p > 0.69), suggesting the complete dependence of HK-associated protective effects on substrate availability. All data represent the means ± S.E. for at least three independent experiments, with the following exception: Data depicted at 1.5 h (infinity ) represent results from a pair of independent experiments used to define the curves beyond 1 h but not included in the statistical analysis of the data because of sample size limitations. Error bars are shown where they are larger than the symbols used to depict the means.

HB-EGF Increases Endogenous HK Activity and Mimics the Glc-dependent Effects of Ectopic HK Expression-- To address the hypothesis that endogenous HK activity could contribute to the salutary effects of growth factors, we first examined the ability of HB-EGF to increase endogenous HK activity and Glc metabolism in HsPTC. In preliminary experiments, HB-EGF increased total HK activity in a concentration- and time-dependent manner, with maximal HK induction observed within 12-24 h of exposure to >= 1 nM HB-EGF (apparent ED50 ~ 0.1 nM). As shown in Fig. 8A, 10 nM HB-EGF increased HK activity by over 25% (21.0 ± 1.1 versus 16.6 ± 1.1 units/g of protein; p < 0.03) at 24 h, and Fig. 8B demonstrates that these changes were associated with ~50% net increases in both Glc utilization (3.9 ± 0.2 versus 2.8 ± 0.2 mmol/g of protein/6 h; dagger , p < 0.03) and lactate accumulation (6.3 ± 0.5 versus 4.1 ± 0.3 mmol/g of protein/6 h; *, p < 0.002). We then examined whether these changes were associated with altered susceptibility to acute oxidant-induced cell death. In the absence of HB-EGF pretreatment, 10 mM H2O2 more than doubled the number of apoptotic cells within 40 min (Fig. 8C; *, p < 0.005 versus unstressed control cells), and these results are consistent with the corresponding responses depicted in Figs. 6A and 7. In contrast, pretreatment of paired cell monolayers with 10 nM HB-EGF for 24 h completely prevented this increase in acute oxidant-induced apoptosis (Fig. 8D; dagger , p = 0.02 and *, p < 0.004 versus time-paired HB-EGF-naïve control cells). As shown in Fig. 9, the protective effect of HB-EGF pretreatment was also fully abolished by the removal of Glc from the media, suggesting similar Glc dependence and a requirement for metabolism. All other factors being equal, the rates of oxidant-induced apoptosis were uniformly higher in the absence of Glc, which is compatible with the results presented in Fig. 7 and suggests intrinsic Glc-dependent protective mechanisms in these cells.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 8.   HB-EGF pretreatment mimics the effect of ectopic HK expression. As shown in A, HsPTC pretreatment with 10 nM HB-EGF increased total HK activity at 24 h (*, p < 0.03), and, as demonstrated in B, this increase was temporally associated with net increases in both Glc utilization and lactate accumulation (, +HB-EGF; open circle , -HB-EGF; dagger , p < 0.03 and *, p < 0.002, respectively). C, in the absence of HB-EGF pretreatment, 10 mM H2O2 increased apoptosis normally (black-diamond ; *, p < 0.005 versus unstressed control cells, diamond ). In D, it can be appreciated that HB-EGF pretreatment (black-square) completely prevented this acute increase in oxidant-induced apoptosis (dagger , p = 0.02 and *, p < 0.004 versus corresponding time-paired HB-EGF-naïve cells; see C). In contrast, HB-EGF had no corresponding independent effects on basal apoptosis in unstressed HsPTC ().


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 9.   The cytoprotective effects of HB-EGF pretreatment are also Glc-dependent. To directly address the substrate dependence of the protective effects of HB-EGF, we examined HB-EGF-pretreated cells (10 nM × 24 h) for susceptibility to acute oxidant-induced apoptosis in both the presence and absence of Glc. Consistent with the results shown in Fig. 8, HB-EGF pretreatment decreased acute oxidant-induced apoptosis in the presence (black-square; *, p < 0.05) but not the absence () of Glc. Rates of apoptosis were uniformly higher in the absence of Glc (open circle , ) when compared with identical cells with access to physiologic levels of Glc (, black-square), consistent with the presence of intrinsic Glc-dependent protective mechanisms.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, we have clearly shown that primary increases in HK activity, vis-à-vis ectopic HK expression, are associated with decreased renal epithelial cell susceptibility to oxidant-induced cell death. In parallel, we have demonstrated that HB-EGF and associated increases in endogenous HK activity have similar cytoprotective benefits. The uniform Glc dependence of these effects suggests a metabolic requirement for substrate availability and is compatible with the contention that they require Glc phosphorylation by HKs. Coupled with our previous findings (29), these results are also compatible with the hypothesis that HKs play an important role in the anti-apoptotic effects of growth factors.

Because cell death cannot be fully defined by, or ascribed to, a single biochemical parameter, we monitored multiple indices of cell viability and integrity following severe acute oxidative stress. Identical results obtained using multiple independent measures validated the ability of increased HK activity to prevent acute oxidant-induced cell death. Ectopic HK expression was associated with improved cell morphology, decreased cell detachment, decreased apoptosis, and reduced cytolysis in H2O2-stressed cells. Rapid decreases in the net reductive capacity of HsPTC preceded the appearance of markers of apoptosis and cell death. As the earliest demonstrable response to acute oxidative stress, these changes suggest an antecedent imbalance between reductant consumption and production. Given the dependence of tetrazolium bioreduction upon Glc metabolism (37, 38),3 they are fully compatible with a role for Glc metabolism in these responses. Characteristic apoptotic changes also uniformly preceded the loss of plasma membrane integrity in oxidant-stressed cells, suggesting that cytolysis may represent a secondary effect in these cells. These findings are consonant with our previous demonstration that ectopic HK expression promotes cell survival by preventing early apoptotic events following growth factor withdrawal (29). Enhanced oxidant-induced apoptotic responses in both untransfected and HKI-overexpressing HsPTC in the absence of Glc are also suggestive of intrinsic Glc-dependent protective mechanisms that presumably involve endogenous HK activity. Indirect support for cytoprotective roles for HKs may also be found in the reported association between HKI expression and recovery of ventricular function in a rat myocardial infarction model (44).

Although facilitative Glc transporter overexpression failed to fully mimic the effects of ectopic HK expression, our findings are not incompatible with previous reports of salutary effects associated with Glc transporter overexpression (8, 45), and they do not exclude a role for endogenous Glc transporters in our findings. Major control over cellular Glc uptake and utilization is shared between both transport and phosphorylation (46), and because metabolic control may be variably distributed between these functionally interactive processes under differing cellular conditions (47), it is likely that Glc transport plays an important role in our findings. However, the inability of GLUT1 overexpression to functionally substitute for ectopic HKI expression clearly suggests that substrate entry alone is not sufficient to protect cells from acute oxidant-induced cell death. These findings are compatible with previously demonstrated requirements for Glc metabolism in cellular recovery from oxidative post-hypoxic injury (2, 4, 6, 8). Based upon both the present findings and our previous studies in fibroblasts (29), we speculate that the protective functions of Glc specifically require its phosphorylation by HKs.

The exact mechanisms whereby ectopic HK expression protects HsPTC against oxidant-induced cell death are not known. However, HK activity could contribute to these effects in a number of nonexclusive ways. As a major determinant of reduced glutathione (GSH) generation (48), increased HK activity could promote metabolic flux through the pentose phosphate pathway and thereby increase both NADPH generation and the coupled reduction of glutathione (7). These changes would be predicted to directly and favorably influence cellular redox status. The association between net cellular reductive capacity and oxidant-induced apoptosis is consistent with such a possibility, as is an association between increased cellular GSH content and increased HK activity.4 The reported ability of EGF to increase pentose phosphate pathway flux in proximal tubule cells (49) is also compatible with this possibility and with our present findings. Alternatively, increased HK activity may energetically favor cell survival by enhancing glycolytic flux. The importance of cellular ATP content in cell viability is widely accepted (6, 50), and Glc plays a major role in the maintenance of intracellular ATP. The widespread use of Glc removal and glycolytic inhibitors in ATP depletion models of proximal tubule injury constitutes tacit acknowledgment of the importance of Glc metabolism to survival in this cell type. Lastly, HKs, specifically the HKI and HKII isoforms, are distinguished from all other glycolytic enzymes by their capacity to physically associate with mitochondria and directly couple the first committed step of Glc metabolism to oxidative phosphorylation (29, 51-53). Mitochondria play a pivotal role in apoptotic cell death, and we have recently shown that mitochondrial HK association promotes both mitochondrial integrity and cell survival following growth factor withdrawal, independent of downstream glycolytic flux (29). Given the inherent complexities of metabolic regulation, it is possible, and even likely, that other consequences of metabolism (e.g. pHi) contribute to the protective effects of Glc. An exhaustive examination of these individual possibilities, however, is beyond the scope of the present work and remains for future studies to address.

The exogenous H2O2 concentrations used for these studies may exceed those anticipated in vivo. They are, however, comparable in magnitude to those employed previously in both the characterization of this cell line and its validation as a cell culture model of oxidant injury (19-21). They are also comparable to the minimum H2O2 concentrations reported to consistently induce rapid cell death in isolated rat proximal tubular segments in the presence of physiologic concentrations of Glc (43). Because oxidant-induced cell death will necessarily reflect the balance between incident stress and intrinsic protective mechanisms, it is reasonable to assume that the observed salutary effects of increased HK activity under conditions of severe acute oxidative stress would also have implications for lesser degrees of stress. Our observations of qualitatively similar, albeit temporally delayed, responses to lower concentrations of H2O2 are compatible with this inference. It is also important to note that the conditions selected for study in the present work greatly facilitated the examination of these effects by increasing the signal-to-noise ratio and by compressing the time frame for analysis, thereby avoiding the confounding pro-apoptotic influence of prolonged culture (>24 h) in the absence of serum.

In conclusion, we have shown that increased HK activity, of either ectopic or endogenous origin, is associated with decreased HsPTC susceptibility to oxidant-induced cell death. The effective changes in HK activity were comparable in magnitude to those previously shown to mimic the anti-apoptotic effects of growth factors in cultured fibroblasts (29). They are also similar to reported changes in endogenous HK activity both in vivo (11-14, 54, 55) and in a variety of cell culture models (31, 32, 56).5 HB-EGF expression is increased in a wide variety of renal injury models, including ischemia-reperfusion injury where both protective and reparative roles have been proposed for this growth factor (22, 23). It is therefore of considerable interest that HB-EGF mimicked the cytoprotective effects of ectopic HK expression and was associated with increased endogenous HK activity and Glc metabolism. These findings suggest metabolic adaptations relevant to the study of ischemia-reperfusion injury, as well as the intriguing possibility that increased HK activity may contribute to the salutary effects of growth factors in the kidney (22). Indirect support for this hypothesis may be found in recent descriptions of Glc-dependent interleukin-3-mediated hematopoietic cell survival (45, 57, 58) and an associated decrease in HK expression in these cells following growth factor withdrawal (58). Although the Glc dependence of other anti-apoptotic effects of growth factors has not been fully examined, the present work, coupled with our previous findings (29), could suggest a general role for both HK activity and Glc metabolism in growth factor-mediated survival in diverse cell types. As a corollary of these hypotheses, HKs may constitute potential therapeutic targets to prevent or mitigate acute oxidant renal injury. Lastly, it would be attractive to speculate that adaptive changes in HK activity in normal cells may have a maladaptive counterpart in cancer cells, where glycolytic capacity is known to correlate with both proliferative capacity and cell survival. Markedly increased HK expression and activity are central features of the classical biochemical phenotype of tumor cells detailed by Warburg (59) in the early part of the last century. These changes also constitute the principal biochemical basis for the use of positron emission tomographic imaging of fluorodeoxyglucose uptake to detect tumor metastases (60). Taken together, it is reasonable to postulate that increased HK activity may contribute to the ability of a wide range of cell types to evade programmed cell death. Thus, our findings not only suggest mechanisms whereby growth factors may exert their salutary effects on acute oxidant injury but also have specific physiologic, pathophysiologic, and possibly therapeutic implications.

    ACKNOWLEDGEMENTS

We thank Dr. A. Katzen (Department of Molecular Genetics, University of Illinois at Chicago) for the use of the Zeiss Axioplan 2 fluorescence microscopy system employed in these studies.

    FOOTNOTES

* This work was supported by grants-in-aid from the National Kidney Foundation of Illinois (to R. B. R.) and the American Heart Association of Metropolitan Chicago (to R. B. R.), as well as by a United States Department of Veterans Affairs Merit Review Award (to R. B. R.) and National Institutes of Health Grant AG-16927 (to N. H.). Portions of this work were presented in preliminary form at the 6th Annual AstraZeneca Cardiovascular Young Investigators' Forum, August 19, 2000, in Quebec City, Quebec, Canada and at the 33rd Annual Meeting of the American Society of Nephrology, October 14, 2000, in Toronto, Ontario, Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Dept. of Medicine, Section of Nephrology, University of Illinois at Chicago College of Medicine (M/C 793), 820 South Wood St., Rm. 418W Clinical Sciences North, Chicago, IL 60612-7315. Tel.: 312-569-7249; Fax 312-996-7378; E-mail: RBRobey@uic.edu.

Published, JBC Papers in Press, December 18, 2001, DOI 10.1074/jbc.M110927200

2 Originally designated HK-2 cells, this nomenclature is not used in the present work to avoid confusion with the HKII isoform.

4 Robey, R. B., Ma, J., Santos, A. V. P., Noboa, O. A., Coy, P. E., and Bryson, J. M. (January 8, 2002) J. Biol. Chem. DOI 10.1074/jbc.M111722200.

5 Coy, P. E., Taneja, N., Lee, I., Hecquet, C., Bryson, J. M., and Robey, R. B. (2002) Am. J. Physiol., in press (DOI 10.1152/ajprenal.00093.2001).

3 J. M. Bryson and R. B. Robey, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: Glc, glucose; DAPI, 4',6'-diamidino-2-phenylindole; EGF, epidermal growth factor; HB-EGF, heparin-binding EGF-like growth factor; HBSS, Hanks' balanced salt solution; HK, hexokinase; HsPTC, Homo sapiens proximal tubule cells; LDH, lactate dehydrogenase; m.o.i., multiplicity of infection; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; PI, propidium iodide; GLUT1, glucose transporter 1; rAd, recombinant adenovirus; HKI, hexokinase I; wt, wild-type; GSH, reduced glutathione.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Neely, J. R., and Grotyohann, L. W. (1984) Circ. Res. 55, 816-824[Abstract/Free Full Text]
2. Hattori, H., and Wasterlain, C. G. (1990) Ann. Neurol. 28, 122-128[CrossRef][Medline] [Order article via Infotrieve]
3. Kelleher, J. A., Chan, P. H., Chan, T. Y. Y., and Gregory, G. A. (1993) Stroke 24, 855-863[Abstract/Free Full Text]
4. Schaefer, S., Prussel, E., and Carr, L. J. (1995) J. Mol. Cell. Cardiol. 27, 2167-2176[CrossRef][Medline] [Order article via Infotrieve]
5. Allen, C. B., and White, C. W. (1998) Am. J. Physiol. 274, L159-L164[Abstract/Free Full Text]
6. Saikumar, P., Dong, Z., Patel, Y., Hall, K., Hopfer, U., Weinberg, J. M., and Venkatachalam, M. A. (1998) Oncogene 17, 3401-3415[CrossRef][Medline] [Order article via Infotrieve]
7. Tian, W.-N., Braunstein, L. D., Apse, K., Pang, J., Rose, M., Tian, X., and Stanton, R. C. (1999) Am. J. Physiol. 276, C1121-C1131[Abstract/Free Full Text]
8. Malhotra, R., and Brosius, F. C., III (1999) J. Biol. Chem. 274, 12567-12575[Abstract/Free Full Text]
9. Moley, K. H., and Mueckler, M. M. (2000) Apoptosis 5, 99-105[CrossRef][Medline] [Order article via Infotrieve]
10. Grossbard, L., and Schimke, R. T. (1966) J. Biol. Chem. 241, 3546-3560[Abstract/Free Full Text]
11. Dubach, U. C., and Recant, L. (1960) J. Clin. Invest. 39, 1364-1371[Medline] [Order article via Infotrieve]
12. Anderson, J. W., and Stowring, L. (1973) Am. J. Physiol. 224, 930-936
13. Steer, K. A., Sochor, M., Gonzalez, A.-M., and McLean, P. (1982) FEBS Lett. 150, 494-498[CrossRef][Medline] [Order article via Infotrieve]
14. Sochor, M., Kunjara, S., and McLean, P. (1988) Horm. Metabol. Res. 20, 676-681[Medline] [Order article via Infotrieve]
15. Schmidt, U., Marosvari, I., and Dubach, U. C. (1975) FEBS Lett. 53, 26-28[CrossRef][Medline] [Order article via Infotrieve]
16. Vandewalle, A., Wirthensohn, G., Heidrich, H.-G., and Guder, W. G. (1981) Am. J. Physiol. 240, F492-F500
17. Lawrence, G. M., and Trayer, I. P. (1984) Histochem. J. 16, 697-708[CrossRef][Medline] [Order article via Infotrieve]
18. Preller, A., and Wilson, J. E. (1992) Arch. Biochem. Biophys. 294, 482-492[CrossRef][Medline] [Order article via Infotrieve]
19. Ryan, M. J., Johnson, G., Kirk, J., Fuerstenberg, S. M., Zager, R. A., and Torok-Storb, B. (1994) Kidney Int. 45, 48-57[Medline] [Order article via Infotrieve]
20. Zager, R. A., and Burkhart, K. (1997) Kidney Int. 51, 728-738[Medline] [Order article via Infotrieve]
21. Zager, R. A., and Burkhart, K. M. (1998) Kidney Int. 53, 1661-1672[CrossRef][Medline] [Order article via Infotrieve]
22. Hammerman, M. R., Safirstein, R., Harris, R. C., Toback, F. G., and Humes, H. D. (2000) Am. J. Physiol. 279, F3-F11
23. Homma, T., Sakai, M., Cheng, H. F., Yasuda, T., Coffey, R. J. J., and Harris, R. C. (1995) J. Clin. Invest. 96, 1018-1025[Medline] [Order article via Infotrieve]
24. Humes, H. D., Cieslinski, D. A., Coimbra, T. M., Messana, J. M., and Galvao, C. (1989) J. Clin. Invest. 84, 1757-1761[Medline] [Order article via Infotrieve]
25. Coimbra, T. M., Cieslinski, D. A., and Humes, H. D. (1990) Am. J. Physiol. 259, F438-F443[Abstract/Free Full Text]
26. Norman, J. T., Tsau, Y.-K., Bacay, A., and Fine, L. G. (1990) Clin. Sci. 78, 445-450[Medline] [Order article via Infotrieve]
27. Racusen, L. C., Monteil, C., Sgrignoli, A., Lucskay, M., Marouillat, S., Rhim, J. G. S., and Morin, J.-P. (1997) J. Lab. Clin. Med. 129, 318-329[CrossRef][Medline] [Order article via Infotrieve]
28. Becker, T. C., Noel, R. J., Coats, W. S., Gómez-Foix, A. M., Alam, T., Gerard, R. D., and Newgard, C. B. (1994) Methods Cell Biol. 43, 161-189
29. Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., and Hay, N. (2001) Genes Dev. 15, 1406-1418[Abstract/Free Full Text]
30. Robey, R. B., Osawa, H., Printz, R. L., and Granner, D. K. (1996) BioTechniques 20, 40-42[Medline] [Order article via Infotrieve]
31. Robey, R. B., Ma, J., and Santos, A. V. P. (1999) Am. J. Physiol. 277, F742-F749[Abstract/Free Full Text]
32. Robey, R. B., Raval, B. J., Ma, J., and Santos, A. V. P. (2000) Kidney Int. 57, 2308-2318[CrossRef][Medline] [Order article via Infotrieve]
33. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
34. Barltrop, J. A., Owen, T. C., Cory, A. H., and Cory, J. G. (1991) Bioorg. Med. Chem. Lett. 1, 611-614[CrossRef]
35. Slater, T. F., Sawyer, B., and Sträuli, U. (1963) Biochim. Biophys. Acta 77, 383-393[Medline] [Order article via Infotrieve]
36. Berridge, M. V., and Tan, A. S. (1993) Arch. Biochem. Biophys. 303, 474-482[CrossRef][Medline] [Order article via Infotrieve]
37. Vistica, D. T., Skehan, P., Scudiero, D., Monks, A., Pittman, A., and Boyd, M. R. (1991) Cancer Res. 51, 2515-2520[Abstract/Free Full Text]
38. Segu, V. B. G., Li, G., and Metz, S. A. (1998) Metabolism 47, 824-830[CrossRef][Medline] [Order article via Infotrieve]
39. Idziorek, T., Estaquier, J., De, Bels, F., and Ameisen, J. C. (1995) J. Immunol. Meth. 185, 249-258[CrossRef][Medline] [Order article via Infotrieve]
40. Robey, R. B., Ruiz, O., Santos, A. V. P., Ma, J., Kear, F., Wang, L.-J., Li, C.-J., Bernardo, A. A., and Arruda, J. A. L. (1998) Biochemistry 37, 9894-9901[CrossRef][Medline] [Order article via Infotrieve]
41. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. (1997) Genes Dev. 11, 701-713[Abstract/Free Full Text]
42. Courjault-Gautier, F., Chevalier, J., Abbou, C. C., Chopin, D. K., and Toutain, J. H. (1995) J. Am. Soc. Nephrol. 5, 1949-1963[Abstract/Free Full Text]
43. Zager, R. A. (1992) J. Clin. Invest. 90, 711-719[Medline] [Order article via Infotrieve]
44. Yonekura, K., Eto, Y., Yokoyama, I., Matsumoto, A., Sugiura, S., Monomura, S., Kirimoto, T., Hayashi, Y., Omata, M., and Aoyagi, T. (2000) Basic Res. Cardiol. 95, 343-348[CrossRef][Medline] [Order article via Infotrieve]
45. Plas, D. R., Talapatra, S., Edinger, A. L., Rathmell, J. C., and Thompson, C. B. (2001) J. Biol. Chem. 276, 12041-12048[Abstract/Free Full Text]
46. Kashiwaya, Y., Sato, K., Tsuchiya, N., Thomas, S., Fell, D. A., Veech, R. L., and Passonneau, J. V. (1994) J. Biol. Chem. 269, 25502-25514[Abstract/Free Full Text]
47. Srere, P. (1994) Trends Biochem. Sci. 19, 519-520[CrossRef][Medline] [Order article via Infotrieve]
48. Kurata, M., Suzuki, M., and Agar, N. S. (2000) Comp. Haematol. Int. 10, 59-67
49. Stanton, R. C., and Seifter, J. L. (1988) Am. J. Physiol. 254, C267-C271[Abstract/Free Full Text]
50. Lieberthal, W., Menza, S. A., and Levine, J. S. (1998) Am. J. Physiol. 274, F315-F327[Abstract/Free Full Text]
51. BeltrandelRio, H., and Wilson, J. E. (1991) Arch. Biochem. Biophys. 286, 183-194[CrossRef][Medline] [Order article via Infotrieve]
52. BeltrandelRio, H., and Wilson, J. E. (1992) Arch. Biochem. Biophys. 299, 667-677
53. BeltrandelRio, H., and Wilson, J. E. (1992) Arch. Biochem. Biophys. 299, 116-124[CrossRef][Medline] [Order article via Infotrieve]
54. Braithwaite, S. S., Palazuk, B., Colca, J. R., Edwards, C. W., III, and Hofmann, C. (1995) Diabetes 44, 43-48[Abstract]
55. Allen, C. B., Guo, X.-L., and White, C. W. (1998) Am. J. Physiol. 274, L320-L329[Abstract/Free Full Text]
56. Riddle, S. R., Ahmad, A., Ahmad, S., Deeb, S. S., Makki, M., Schneider, B. K., Allen, C. B., and White, C. W. (2000) Am. J. Physiol. 278, L407-L416[Abstract/Free Full Text]
57. Kan, O., Baldwin, S. A., and Whetton, A. D. (1994) J. Exp. Med. 180, 917-923[Abstract/Free Full Text]
58. Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., and Thompson, C. B. (2001) Mol. Cell. Biol. 21, 5899-5912[Abstract/Free Full Text]
59. Warburg, O. (1956) Science 123, 309-314[Free Full Text]
60. Muzi, M., Freeman, S. D., Burrows, R. C., Wiseman, R. W., Link, J. M., Krohn, K. A., Graham, M. M., and Spence, A. M. (2001) Nuclear Med. Biol. 28, 107-116[CrossRef]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Miyamoto, M. Rubio, and M. A. Sussman
Nuclear and mitochondrial signalling Akts in cardiomyocytes
Cardiovasc Res, May 1, 2009; 82(2): 272 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Abu-Hamad, H. Zaid, A. Israelson, E. Nahon, and V. Shoshan-Barmatz
Hexokinase-I Protection against Apoptotic Cell Death Is Mediated via Interaction with the Voltage-dependent Anion Channel-1: MAPPING THE SITE OF BINDING
J. Biol. Chem., May 9, 2008; 283(19): 13482 - 13490.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Sun, S. Shukair, T. J. Naik, F. Moazed, and H. Ardehali
Glucose Phosphorylation and Mitochondrial Binding Are Required for the Protective Effects of Hexokinases I and II
Mol. Cell. Biol., February 1, 2008; 28(3): 1007 - 1017.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Moin, M. Panteva, and S. Jameel
The Hepatitis E Virus Orf3 Protein Protects Cells from Mitochondrial Depolarization and Death
J. Biol. Chem., July 20, 2007; 282(29): 21124 - 21133.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
M. Kim, J.-H. Lim, C. S. Ahn, K. Park, G. T. Kim, W. T. Kim, and H.-S. Pai
Mitochondria-Associated Hexokinases Play a Role in the Control of Programmed Cell Death in Nicotiana benthamiana
PLANT CELL, September 1, 2006; 18(9): 2341 - 2355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. P. Biju, Y. Akai, N. Shrimanker, and V. H. Haase
Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1217 - F1226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. S. da-Silva, A. Gomez-Puyou, M. T. de Gomez-Puyou, R. Moreno-Sanchez, F. G. De Felice, L. de Meis, M. F. Oliveira, and A. Galina
Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense: STEADY-STATE ADP FORMATION AS A REGULATORY MECHANISM OF MEMBRANE POTENTIAL AND REACTIVE OXYGEN SPECIES GENERATION IN MITOCHONDRIA
J. Biol. Chem., September 17, 2004; 279(38): 39846 - 39855.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Taneja, P. E. Coy, I. Lee, J. M. Bryson, and R. B. Robey
Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance
Am J Physiol Cell Physiol, August 1, 2004; 287(2): C548 - C557.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Majewski, V. Nogueira, R. B. Robey, and N. Hay
Akt Inhibits Apoptosis Downstream of BID Cleavage via a Glucose-Dependent Mechanism Involving Mitochondrial Hexokinases
Mol. Cell. Biol., January 15, 2004; 24(2): 730 - 740.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. C. Rathmell, C. J. Fox, D. R. Plas, P. S. Hammerman, R. M. Cinalli, and C. B. Thompson
Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival
Mol. Cell. Biol., October 15, 2003; 23(20): 7315 - 7328.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. B. Robey
Caveat experimentor: reporting expression profiling data involving multiple, functionally redundant isoforms
J. Leukoc. Biol., September 1, 2003; 74(3): 307 - 308.
[Full Text] [PDF]


Home page
Cancer Res.Home page
A.-S. Belzacq, H. L. A. Vieira, F. Verrier, G. Vandecasteele, I. Cohen, M.-C. Prevost, E. Larquet, F. Pariselli, P. X. Petit, A. Kahn, et al.
Bcl-2 and Bax Modulate Adenine Nucleotide Translocase Activity
Cancer Res., January 15, 2003; 63(2): 541 - 546.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Robey, J. Ma, A. V. P. Santos, O. A. Noboa, P. E. Coy, and J. M. Bryson
Regulation of Mesangial Cell Hexokinase Activity and Expression by Heparin-binding Epidermal Growth Factor-like Growth Factor. EPIDERMAL GROWTH FACTORS AND PHORBOL ESTERS INCREASE GLUCOSE METABOLISM VIA A COMMON MECHANISM INVOLVING CLASSIC MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY ACTIVATION AND INDUCTION OF HEXOKINASE II EXPRESSION
J. Biol. Chem., April 19, 2002; 277(17): 14370 - 14378.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/13/11392    most recent
M110927200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryson, J. M.
Right arrow Articles by Robey, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryson, J. M.
Right arrow Articles by Robey, R. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement